A Phase II Single-Center, Randomized, Double-Blind Study in Subjects with a History of Opioid Abuse to Evaluate the Dose-Response for Flushing and Safety and Tolerability of Varying Doses of Niacin in Combination with 40 mg of an Opioid vs. 40mg of an Opioid Alone

Trial Profile

A Phase II Single-Center, Randomized, Double-Blind Study in Subjects with a History of Opioid Abuse to Evaluate the Dose-Response for Flushing and Safety and Tolerability of Varying Doses of Niacin in Combination with 40 mg of an Opioid vs. 40mg of an Opioid Alone

Completed
Phase of Trial: Phase II

Latest Information Update: 05 Mar 2008

At a glance

  • Drugs Niacin (Primary) ; Oxycodone
  • Indications Pain
  • Focus Pharmacodynamics; Therapeutic Use
  • Sponsors Acura Pharmaceuticals
  • Most Recent Events

    • 05 Mar 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top